Actionable news
0
All posts from Actionable news
Actionable news in ABBV: ABBVIE Inc,

AbbVie And Bristol-Myers Squibb Strike Oncology Clinical Alliance To Assess Rova-T plus Opdivo And Opdivo + Yervoy Regimen

AbbVie Inc. (NYSE: ABBV) and Bristol-Myers Squibb Company (NYSE: BMY) revealed Monday a clinical study alliance to assess the safety, tolerability and efficacy of the former's investigational biomarker-specific antibody drug conjugate Rova-T in combination with the latter's Opdivo and Opdivo + Yervoy. They were meant for the treatment of relapsed extensive-stage small cell lung cancer (SCLC).

Both companies said the Phase 1/2 clinical program would explore the possibility of integrating Bristol-Myers Squibb's immuno-oncology agents in conjunction with AbbVie's investigational antibody drug...


More